Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sonja Nelson Insider Profile
4 Followers
Sonja Nelson, CFO at ImmunityBio, holds 0.00 shares in Ambrx Biopharma (Ticker: AMAM), holds 100.71K shares in Motus Gi Holdings (Ticker: MOTS), holds 15.41K shares in ImmunityBio (Ticker: IBRX).
Sonja Nelson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Sonja Nelson
Sonja Nelson's Trading History
ImmunityBio
Jan 13, 2021
CFO
Uninformative Buy
34.89K
$65.49K
Motus Gi Holdings
Jan 07, 2022
Director
Uninformative Buy
―
$3.63K
Ambrx Biopharma
Mar 07, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Sonja Nelson's performance on stock
You May Also Like
Sonja Nelson insider profile FAQ
What is the percentage of profitable transactions made by Sonja Nelson?
The percentage of profitable transactions made by Sonja Nelson is ―.
What is the average return per transaction made by Sonja Nelson?
The average return per transaction made by Sonja Nelson is ―.
What stocks does Sonja Nelson hold?
Sonja Nelson holds: IBRX, MOTS, AMAM stocks.
What was Sonja Nelson’s latest transaction?
Sonja Nelson latest transaction was an Uninformative Sell of ―.
What was Sonja Nelson's most profitable transaction?
Sonja Nelson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Sonja Nelson's role in ImmunityBio?
Sonja Nelson's role in ImmunityBio is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.